28.02.2014 • News

Eastman Board Approves $1 Billion Share Buyback

The board of U.S. chemical producer Eastman has approved the repurchase of up to $1 billion of the company's common stock. Chief financial officer Curt Espeland said the buyback and the quarterly cash dividend of $0.35 per share reflects the company's solid financial position, including its strong cash flow.

Eastman said the share repurchases will be made from time to time in either the open market or private transactions. The timing, volume and nature of the repurchases will be at the discretion of management, subject to market conditions and may be suspended or discontinued at any time.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read